SipNose is a brand driven by a team of professionals with expertise in technology, engineering, medical applications, and science. With their Israeli headquarters and a presence in the US, SipNose combines their knowledge to provide innovative products and services. Led by Dr.

Iris Shichor and Mr. Daniel Shahaf, SipNose offers cutting-edge solutions in the field of intranasal treatments. Dr.

Shichor, with her strong background in biochemistry and physiology, brings extensive experience in research and development, as well as product management. Her expertise in drug delivery systems and product development has been crucial to SipNose's success. Mr.

Shahaf, on the other hand, has a deep understanding of stress elimination in respiratory drug applications, and his experience as an inventor and developer in medical platforms for the respiratory system has been invaluable. Additionally, SipNose boasts an Advisory Board consisting of industry experts in the medical and regulatory domains. With a focus on regulatory compliance, medical knowledge, and business acumen, SipNose ensures the quality and safety of their products.

Get in touch with SipNose to explore the possibilities of their intranasal therapy for treatment and prevention, intranasal vaccination, and other innovative intranasal treatments